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Abstract To study the tumor cell autonomous processes
of metastasis, an in vivo tumor metastasis model is re-
quired that excludes the involvement of the innate immune
system. For this purpose we used the established syngeneic
MTLn3 cell – Fischer 344 tumor model. MTLn3 cells are
efficiently eradicated by NK cells in vivo. Using isolated
cell systems, we provide evidence for apoptosis-induction
by IL-2 activated NK cells, but not T-cells, despite the
expression of MHC class I. This is largely mediated by the
perforin/granzyme B pathway in MTLn3 cells in a caspase-
dependent manner. Temporal in vivo depletion of NK cells
by an antibody-based method, dramatically improved col-
onization of the lungs by MTLn3 cells, from 5 metastases
in the untreated animals to 130 metastases in the NK-de-
pleted animals. Thus, we improved the syngeneic MTLn3-
Fischer 344 tumor model by temporal depletion of NK
cells of which the advantages over the use of immunode-
ficient animals are evident.
Keywords MTLn3 cells  Fischer 344 rats  NK cells 
Metastasis
Abbreviations
ADCC antibody dependent cellular cytotoxicity
CMA concanamycin A
CTL cytotoxic T-lymphocyte
E/T effector target cell ratio
FACS fluorescence activated cell sorter
FAK focal adhesion kinase
FRNK FAK-related non-kinase
IL-2 interleukin 2
MHC Major histocompatibility complex
NK cell natural killer cell
PI propidium iodide
Introduction
In the ongoing search for an anti-cancer drug, numerous
in vitro and in vivo models have been generated to study
tumor cell biology. Although in in vitro models many as-
pects of tumor cell biology can be studied, relevant in vivo
models are essential to define the ultimate biological rel-
evance of in vitro findings for the intact organism. Thus,
the complex environment including local presence of
growth factors and chemokines, host immune system and
angiogenesis are essential determinants of tumor develop-
ment and progression including the biological processes
essential in metastasis formation [1].
In vivo tumor growth is studied in two different animal
models: syngeneic models and immunodeficient models.
As in syngeneic models the transplanted cells, the tumor
microenvironment, and the host are not only from the same
species, but from the same strain of inbred animals, no
alloreactivity should occur. Given the importance of tumor
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versus immune cell interactions as principal requirements
for tumor progression and metastasis formation, syngeneic
models are preferred. However, prolonged culturing of
syngeneic tumor cells in vitro may affect the expression of
adhesion molecules or antigen expression molecules such
as the Major Histocompatibility Complex (MHC) families,
rendering these syngeneic cells a target for the immune
system. Therefore, other in vivo models, such as the use of
immunodeficient mice are being employed. The most used
immunodeficient mice (SCID, Rag-/-) lack the adaptive
immune response, but still harbour large numbers of cells
of the innate immune system. Additionally, mice are being
used that, due to combined knock out of the Rag-gene and
the common gamma chain (Rag-/- Ec-/-), lack both the
adaptive and innate immune response.
Two important disadvantages of the use of these
immunodeficient animals are the lack of tumor-immune
cell interactions and the use of cancer cells originating
from other species, i.e. injection of rat cancer cells in mice.
In immunocompetent animals, the cytotoxic response of
the immune system is mediated by two distinct subsets of
lymphocytes: the T-lymphocytes and the Natural Killer
(NK) cells. The T-cells belong to the adaptive immune
system and respond to foreign antigens presented in self
MHC. The NK-cells are an important component of the
innate immune system and function in an antigen-non-
specific manner [2]. NK cell-mediated killing of target
cells is controlled by a balance between activating and
inhibitory signals, of which the latter are mediated by
expression of the appropriate MHC I molecules [2]. Both
types of lymphocytes kill their targets by excretion of
perforin and granzyme B on one hand and by activation of
death-receptors on the other hand. All signals finally con-
verge in activation of the executioner caspase-3, leading to
induction of apoptosis in the target cells.
The rat mammary adenocarcinoma cell line MTLn3 is
an excellent model to mimic breast cancer and its treat-
ment. In the early eighties, Neri and Welch isolated a
founder cell line out of the Fischer 344 rat, which was
named 13762NF [3]. Injection of this cell line into the fat
pad of the Fischer 344 rat resulted in the formation of lung
metastases. Several lung metastases were isolated and one
of the cultured breasts to lung metastases was named
MTLn3. This cell line turned out to be highly metastatic:
when injected into the fat pad of female Fischer 344 rats,
within 3 weeks the lungs of the rats were burdened with
metastases. However, after several passages of in vitro
culturing, this cell line started to lose its metastatic po-
tential [4]. To circumvent this problem, immunodeficient
mice can be used to study these cells under in vivo con-
ditions, indicating an important role for the immune system
in declining metastasis rather than a cell intrinsic phe-
nomenon. Using nude mice, no macro-metastases and only
few micrometastases in the lung could be found five weeks
after injection of the MTLn3 cells in the fat pad [5],
probably due to the NK-mediated killing of metastasizing
cells. The importance of NK-cell mediated killing of tumor
cells is well established in the MADB106 syngeneic tumor
model [6–8] dating back to 1985 [9].
To study the cellular biological processes involved in
metastasis, it is important to develop an improved model
that excludes interference by the immune system. We have
previously used MTLn3 cells to study the mechanisms of
cytostatic-induced apoptosis [10, 11]. In addition, we
studied the role of the non-tyrosine kinase focal adhesion
kinase in the processes involved in tumorigenesis and
metastasis under in vitro circumstances [12]. The goal of
the current study was to improve the MTLn3 cell – Fischer
344 rat syngeneic breast tumor metastasis model, to allow
the unbiased analysis of tumor cell dependent metastasis
programs, independent of the innate immune system sur-
veillance.
A model was set up in which killing of the circulating
MTLn3 cells by the innate immune system of Fischer 344
rats was prevented during the metastasis process. In vitro
MTLn3 cells are subject to IL-2 activated NK cell-, but not
T-cell-mediated killing. Killing depended on granzyme-B/
perforin mediated caspase activation and in vivo depletion
of NK cells enabled tail vein injected MTLn3 cells to
highly efficient colonize the lungs. In conclusion, by
depleting NK cells in Fischer 344 rats, we have created an
improved syngeneic model that can be used to study the
biological steps taken place in tumor cells that are essential
in the formation of distant metastasis.
Materials And Methods
Animals
Female Fischer 344 rats weighing 70–80 g were purchased
from Charles River. They were fed ad libitum and kept at a
12 hour light-dark cycle and kept for at least 2 weeks at the
local animal facility before use.
Reagents
Human recombinant interleukin-2 was obtained from
Chiron (Amsterdam, The Netherlands), concanamycin A
from Fluka Chemistry (St. Louis, MO, USA) and annexin-
V from Roch (Base, Switzerland). Annexin-V was labelled
with allophycocyanin (a 652 nm fluorescent probe) (Pro-
zyme, San Leandro, CA, USA). Molecular Probes (Leiden,
The Netherlands) supplied the calcein-AM and the propi-
dium-iodide was purchased from Sigma (St. Louis, MO,
USA). Alpha modified minimal essential medium (a-
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MEM), Fetal Bovine Serum (FBS), phosphate buffered
saline (PBS) and trypsin were from Life Technologies
(Rockville, MD, USA). All other chemicals were of ana-
lytical grade.
Cell lines
MTLn3-tetFRNK cells were used. This cell line is derived
from the MTLn3 cell line and differs only from the founder
cell line when doxycycline is present; in then expresses a
FAK-related non kinase (FRNK) protein [13]. During the
experiments described in this paper, no doxycycline is
present and therefore, we will refer to this cell line as
MTLn3. MTLn3 rat mammary adenocarcinoma cells [3]
were cultured as previously described [10].
NK and T-cells
NK cells were isolated as described previously [14]. Briefly,
spleens were aseptically removed from rats and placed in
10 ml culture medium, consisting of RPMI 1640 (L-gluta-
mine, 25 mM HEPES) supplemented with 10% heat-inac-
tivated FBS, 100 lg/ml streptomycin, 100 IU/ml penicillin,
5 ll lipopolysaccharoids 100 lg/ml, 6.66 ml 7.5% (w/v)
NAHCO3, 0.1 ml 100 mM b-mercapto-ethanol (complete
medium). A single cell suspension was prepared by pressing
the spleen through a sterile open filter chamber (Embrarad,
Sao Paulo, Brasil). The splenocytes were depleted of B-
cells, macrophages and monocytes by allowing these cells
to adhere to nylon-wool for 2 hours (Fenwal laboratories,
Morton Grove, IL, USA) at 37C in complete medium. The
non-adherent cells were collected and cultured in 175 cm2
culture flasks (Greiner, Langentha, Switzerland) in 35 ml
culture medium containing 1000 Cetus units human re-
combinant IL-2 per ml. After 24 hours, the culture medium
was transferred to a centrifuge tube and the non-adherent
cells were washed three times with 10 ml culture medium
without IL-2. The conditioned medium, obtained after
centrifugation, was re-added and the cells were cultured in
this medium for 6 days. To obtain T-cells, the remaining
pellet was resuspended in complete medium containing 100
Cetus units recombinant IL-2 per ml and cultured in R73
coated 175 cm2 culture flasks (6 lg/ml PBS, 6 ml per
TC175, o/n, 4C). Two days later, non-adherent cells were
removed and complete medium containing 100 Cetus units
human recombinant Il-2 per ml was added. Cells were
cultured in this medium for 4 days.
Cytotoxicity assays
MTLn3 cells were harvested and washed twice. They were
labelled by incubation with 1 lM calcein-AM for
15 minutes in culture medium. For some cytotoxicity as-
says, MTLn3 cells were pre-incubated with zVAD-fmk
(100 lM) or DEVD-fmk (100 lM) and these inhibitors
were also added during the co-incubation period. Subse-
quently, these cells were washed and seeded in a 96-well-
U-bottom plate at a density of 100,000 cells in 0.1 ml/well.
The effector cells (NK or T-cells) were added in a volume
of 0.05 ml. For some experiments, to block induction of
apoptosis by the granzyme B/perforin pathway, NK cells
were pre-incubated for 2 hours with 20 nM concanamycin
A (CMA) which was previously proven to be the optimal
concentration to inactivate perforin [14]. After three or six
hours, the 96-well plate was centrifuged for 3 minutes at
1500 rpm at 4C. The supernatant was removed, the cells
were washed with 0.1 ml PBS and the detached cells were
transferred to a new plate. Next, 0.1 ml of trypsin was
added to the original plate and this plate was incubated for
10 minutes at 37C. After trypsinization, the detached cells
and the cells in the PBS were pooled and the plate was
centrifuged (3 min., 1500 rpm 4C). Next, the cells were
suspended in 200 lL binding buffer (10 mM HEPES,
150 mM NaCl, 5 mM KCl, 1 mM MgCl2.6H2O, 1.8 mM
CaCl2.2H2O in Milli Q Water, pH 7,4) containing 0.5 ll
annexin-V (0.5 lg/ll). The cells were incubated (20 min-
utes, 4C) and subsequently washed twice with binding
buffer. Finally, the cells were suspended in 0.2 ml binding
buffer and 10 ll propidium-iodide (PI, 100 lM) was added
shortly before measurement. Samples were analyzed on the
FACScalibur (Becton Dickinson, San Jose, CA). Target
cells were selected by gating the calcein-AM positive cells.
Viable cells are annexin-V-APC and PI-negative, apoptotic
cells are annexin-V-APC positive but PI-negative and ne-
crotic cells are annexin-V-APC- and PI-positive.
MHC-I staining
MTLn3 cells were harvested and incubated for 30 minutes
with 25 ll culture supernatant of mAb OX18 IgG (binding
to rat MHC class I [15]). The cells were washed with PBS
and incubated for 1 hour with the secondary antibody Gt-
anti mouse-alexa 488 in binding buffer. Finally, the cells
were washed and suspended in 0.2 ml binding buffer and
10 ll propidium-iodide (PI, 100 lM) was added shortly
before measurement. MHC-I expression was analyzed on
the FACScalibur (Becton Dickinson).
In vivo metastasis formation
Cells were injected into the lateral tail vein of Fischer 344
rats as described previously [13]. Briefly, MTLn3 cells
were trypsinized, counted, washed twice and resuspended
in PBS. 1 · 105 Viable cells in 0.2 ml PBS were injected
into the lateral tail vein. After 4 weeks, the animals were
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anesthetized with pentobarbital and the lungs were excised
and rinsed in ice-cold PBS. The right lung was cut into
three pieces and fixated in isopentane (used to prepare
tissue homogenates for immunoblot analysis), 4% para-
formaldehyde or Carnoy’s (10% (v/v) acetic acid, 30% (v/
v) chloroform in 60% ethanol). The left lung was injected
with ink solution and thereafter destained in water and
fixated in Fekete’s (4.3% (v/v) acetic acid, 0.35% (v/v)
formaldehyde in 70% ethanol). Lung tumor burden was
determined by counting the number of surface metastases.
Purification of mAb3.2.3 antibody
Culture supernatant was obtained using centrifugation of
the hybridoma culture, followed by filtering through a
0.2 lM pore size filter. Supernatant was passed through a
protein G column (Pharmacia, Uppsala, Sweden). Bound
immunoglobulin was eluted using a pH gradient from pH
7.4 (PBS) to pH 2.7 (0.1 M Glycin-HCl). Each of the peak
fractions obtained was pooled and then dialyzed against
PBS. Finally the protein concentration was diluted to 2 mg/
ml in PBS (protein concentration measured against IgG
standard).
Depletion of NK cells
To deplete NK cells, rats were treated with the monoclonal
anti-CD161A antibody, called mAb3.2.3, on 3 consecutive
days (150 lg in 0.5 ml PBS, i.p.). The next day, rats were
anesthetized with pentobarbital and at least 1 ml blood was
isolated by a heart puncture. After addition of heparin, 2 ml
RPMI was added to the blood and this mixture was care-
fully pipetted on top of 3 ml Ficoll Hypaque and centri-
fuged (20 min. 2000 rpm, room temperature, no brake).
The inter phase that contained the white blood cells was
isolated and washed 2 times with RPMI. White blood cells
were transferred to a V-bottom 96 wells plate, blocked with
5% BSA in PBS for 30 minutes and incubated with alexa-
633 labelled mAb3.2.3 in binding buffer. Cells were wa-
shed twice with binding buffer and prior to flowcytometric
analysis incubated with propidium iodide. Propidium io-
dide negative (= non-necrotic) cells were gated and using
forward-side scatter plots the lymphocytes were gated. By
gating the alexa-633 positive cells, the percentage of NK
cells was determined in the lymphocyte groups.
Statistical analysis
Student’s t test was used to determine significant differ-
ences between two means (p < 0.05). For the in vivo lung
metastasis experiments, statistical significance was deter-
mined by the Mann-Whitney Rank Sum test.
Results
Intravenous injection of MTLn3 cells does not result in
experimental metastasis formation. To study the process of
metastasis we used a syngeneic model consisting of the rat
mammary adenocarcinoma cell line MTLn3 and the Fi-
scher 344 rats. Initially 1 · 105 MTLn3 cells were injected
into the lateral tail vein of the female Fischer 344 rats.
However, after 3 weeks, no lung surface tumors were
detectable (data not shown). Increasing the number of
MTLn3 cells to 5 · 105 and 1 · 106, and prolonging the
period to form metastases to 5 weeks did not result in the
formation of lung tumors. Only when 1 · 106 cells were
injected, a few large lung tumors could be observed
6 weeks post-injection. Importantly, HE stained lung sec-
tions did not harbour any dormant tumor cells or mi-
crometastases and those metastases that were present at the
surface of the lungs were large. This implicated that even
when 1 · 106 tumor cells were injected, few cells survived
in the circulation allowing outgrowth into lung metastases.
Thus, in our hands, the MTLn3 cell line was not able to
colonize the lungs after tail vein injection. Importantly,
when these cells were injected subcutaneously in the
mammary fat pad, after two weeks, the tumors were pal-
pable and were able to grow out into large tumors in four
weeks [13]. Thus, the absence of experimental metastases
results from the lack of survival of MTLn3 cells in the
circulation.
Syngeneic NK- but not T-cells kill MTLn3 cells
A possible explanation of the lack of lung metastases could
be that, despite the use of a syngeneic model, circulating
MTLn3 cells are efficiently eradicated by cells of the im-
mune system shortly after injection. As the cytotoxic
component of the immune response, responsible for erad-
ication of cellular threats comprises the cytotoxic T-cells
and NK-cells, we tested both cell types for their potency to
kill MTLn3 cells. Since the tumor cells are very rapidly
killed in the circulation, no antigen-specific response could
be elicited by the T-cells within that time-frame and
therefore, only the possibility of cross-reactivity was tested
by examining the cytotoxic potential of polyclonally acti-
vated T-cells. To do so, NK cells and T-cells were isolated
from the spleen of Fischer 344 rats, activated by culturing
in IL-2 enriched medium (and anti-CD3 for T-cells), and
followed by an in vitro cytotoxicity assay. For this cyto-
toxicity assay, the cells were co-incubated for 6 hours at an
effector (= NK cells or T-cells)/target (= MTLn3 cells)
ratio (E/T) of 10. The target cells were labelled with a
fluorescent dye, calcein-AM, and prior to the co-incuba-
tion, allowing discrimination using FACS analysis
(Fig. 1A). After the co-incubation of the target and effector
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cells, cells were stained with propidium iodide, which can
only enter necrotic cells, and annexin-633, which recog-
nizes phosphatidyl serine: an early apoptotic marker. Pro-
pidium iodide negative target cells were gated and the
percentage annexin-633 positive (= apoptotic) cells was
determined (Fig. 1B). Exposure of the MTLn3 cells to IL-2
activated NK cells resulted in 50% apoptosis (Fig. 1C),
whereas T-cells did not induce apoptosis of MTLn3 cells.
Importantly, no difference in propidium iodide positive
cells (i.e. necrotic cells) was found between the experi-
mental and control incubations. As NK-cell mediated
killing is controlled by a balance between activating and
inhibitory signals, of which the latter is mediated by
expression of MHC class I, the cytotoxic observations
could be explained by a lack of MHC-class I expression on
the outer membrane of target cells. However, the MTLn3
cells did express MHC class I, as shown by staining with
OX-18 (Fig. 1D). Thus, under in vitro conditions, regard-
less of the presence of MHC-I, syngeneic NK cells are
capable of killing the MTLn3 cells.
NK cells-induced apoptosis of MTLn3 cells is perforin-
and caspase-3 dependent
Since MTLn3 cells do express MHC-I, we wondered
whether the cells were indeed killed by the NK cells via the
classic perforin/granzyme B mediated caspase activation.
To study this, the perforin/granzyme B route was disabled
by pre-treatment with CMA, which irreversibly binds
perforin. Since co-incubation of the target and effector
cells for 6 hours resulted in massive cell death, the co-
incubation period for this set of experiments was reduced
to three hours. Background apoptosis did not exceed 2%
and NK cell induced apoptosis was approximately 19%
(Fig. 2); inhibition of the perforin/granzyme B pathway
caused a significant reduction of NK cell-mediated cyto-
toxicity. To verify that the killing of MTLn3 cells by the
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Fig. 1 NK cells, but not T-cells, induce apoptosis in MHC-I
expressing MTLn3 cells. MTLn3 cells were labeled with calcein-
AM and co-incubated with NK or T-cells (E/T 10) for 6 hours, by
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analysis (D)
co
ntr
ol NK
NK
+
zV
AD
NK
+ z
DE
VD
co
ntr
ol NK
NK
+ z
VA
D
NK
+
zD
EV
D
0
5
10
15
20 - CMA + CMA
%
a
po
pt
o
tic
ce
lls
(A
V+
/P
I- )
Fig. 2 NK cells induce apoptosis of MTLn3 cells via the granzyme-
B/perforin pathway. MTLn3 and NK cells were co-incubated as
described in figure 1, after 3 hours apoptosis was determined. Where
indicated, NK cells were pre-incubated with CMA to prevent
granzyme-B/perforin mediated apoptosis and MTLn3 cells were
pre-incubated with 100 lM zVAD-fmk (pan-caspase inhibitor) or
100 lM zDEVD-fmk (caspase-3 inhibitor)
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NK cells involved the induction of apoptosis, the apoptotic
machinery of the MTLn3 cells was abrogated by using a
pan-caspase inhibitor (zVAD-fmk) or an inhibitor of the
effector caspase-3 (zDEVD-fmk). Previously, we have
shown the apoptosis-inhibiting capacity of these caspase
inhibitors in cytostatic-induced apoptosis of MTLn3 cells
[16]. Pre-treatment of the MTLn3 cells with the caspase
inhibitors zDEVD-fmk and zVAD-fmk significantly re-
duced the percentage of NK cell induced apoptosis. Fi-
nally, the combined addition of CMA and caspase
inhibition reduced apoptosis almost completely albeit that
some residual cell death was present. Again, no differences
between experimental and control incubations in propidi-
um iodide positive cells was found. Thus, Fischer 344 NK
cells kill MTLn3 cells by induction of apoptosis, pre-
dominantly mediated via the granzyme B mediated path-
way.
Depletion of NK cells in the Fischer 344 rat enables
MTLn3 cells to form metastases
The above data indicate that MTLn3 cells are efficiently
killed by NK cells of the Fischer 344 rats by means of
apoptosis. Therefore, the lack of lung metastases may well
be related to efficient NK cell mediated killing of circu-
lating MTLn3 cells. To confirm the potency of NK cells to
prevent metastasis in vivo, NK cells were depleted from
the Fischer 344 rats. For this purpose, rats were injected
intraperitoneally for three consecutive days with 150 lg of
the NK depleting antibody, mAb3.2.3 [17]. To determine
NK cell depletion, one day after the third intraperitoneally
injection blood was isolated from the rats via a heart
puncture. Mono-nuclear cells were isolated and stained for
the NK-cell specific marker NK1.1, followed by flow cy-
tometric analysis to determine the amount of NK cells.
First, using the forward scatter-side scatter plot, the lym-
phocytes were gated (Fig. 3A, left panel) and subsequently,
by gating the NK1.1 positive population, the percentage of
NK cells could be determined (Fig. 3A, right panels). The
lymphocytes isolated from control animals consisted for
approximately 8% of NK cells (Fig. 3B). Treatment of the
rats with the NK depleting antibody reduced the percentage
of NK cells to <0.5%, indicating an efficient depletion of
circulating NK cells.
Next, this method was used to determine the role of NK
cells in MTLn3 cell killing in vivo, and, consequently, the
lack of lung metastasis formation. Therefore, after NK-cell
depletion, Fischer 344 rats were injected with only 100,000
MTLn3 cells. All animals were sacrificed after four weeks
and the lungs were isolated and injected with ink, as de-
scribed previously [13]. In control animals, neither lung
surface inspection nor microscopical analysis of H&E
stained lung sections showed lung tumors and microme-
tastases, respectively. Yet, in the lungs of the NK cell
depleted animals large numbers of tumors were found
(Fig. 4A). In the control group hardly any surface lung
metastases were present. However, in the rats that were
treated with the NK depleting antibody on average more
than 130 lung metastases were present (Fig. 4B and C). In
conclusion, temporal depletion of NK-cells from the Fi-
scher 344 rats causes MTLn3 cells to escape immunosur-
veillance and enables them efficiently to colonize the
lungs.
Discussion
The goal of our study was to improve the MTLn3 cell –
Fischer 344 rat breast tumor metastasis model, to allow the
unbiased analysis of tumor cell dependent metastasis pro-
grams in a syngeneic environment. In our hands, MTLn3
cells were not able to form experimental metastases after
tail vein injection into syngeneic Fischer 344 rats. We
show that MTLn3 cells are efficiently killed by NK cells in
a granzyme B and caspase-3 dependent manner. Eradica-
tion of NK cells by using the NK cell depleting antibody
mAb3.2.3 enables MTLn3 cells to circumvent NK cell
killing in the circulation and allows efficient homing of the
tumor cells to the lungs followed by outgrowth into
metastases. Using this approach, the number of experi-
mental lung surface metastases increased from 5 to 130
upon injection of only 1 · 105 cells, providing an impor-
tant tool to study the different steps involved in experi-
mental metastasis formation.
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Circulating NK cells were depleted by repetitive treat-
ment of the rats with the NK-cell depleting 3.2.3 antibody.
Unfortunately, no other highly NK-cell specific antibody
was available and therefore the presence of NK-cells was
determined by studying the presence of fluorochrome-
conjugated 3.2.3-positive cells in the peripheral blood.
Thus this approach cannot formerly exclude the possibility
that the NK-cells were coated with the 3.2.3 antibody
in vivo. Importantly, validation of this NK-depletion
method by van den Brink et al. [17] not only showed ab-
sence of NK-cells by phenotyping, but also a complete lack
of NK-cell mediated cytotoxicity as well as antibody
dependent cellular cytotoxicity (ADCC), functionally
proving the absence of NK-cells. Therefore, we are confi-
dent that in our model NK-cells are also depleted.
Only 130 experimental lung surface metastases were
formed after inoculation of 1 · 105 cells in NK cell-de-
pleted animals. This indicates that the formation of
experimental metastasis upon injection of MTLn3 cells is a
very inefficient process. In comparison, implantation of
1 · 106 MTLn3 cells in nude mice resulted in 26 lung
metastases [5]. Also, intravenous injection of 2 · 106 se-
lected, highly metastatic CC531-m2 tumor cells resulted
only in several hundred experimental metastases in fully
immunocompetent animals [18]. Thus 130 lung metastases
after inoculation of no more than 1 · 105 MTLn3 cells in
NK-cell depleted animals can be regarded as efficient and
fully dependent on the lack of NK-cells as in non-treated
animals almost no metastases were seen, even after injec-
tion of 1 · 106 cells.
To exclude that the observed lack of metastases after
inoculation of 1 · 106 cells was a supplier-specific phe-
nomenon, the experimental metastasis experiments were
performed in animals ordered at two different suppliers,
Harlan and Charles River. Both experiments did not result
in experimental metastases (data not shown). However,
when the cells were injected subcutaneously in the mam-
mary fat pad, the cells were able to grow out into large
tumors in four weeks [13]. Thus, the lack of experimental
metastases could neither be attributed to the used Fischer
344 rats nor to the preparation of the cells. Moreover, the
mammary fat pad experiment indicates that the lack of
experimental metastases is due to killing of tumor cells in
the circulation and not after extravasation into the target
organ. Since we think it is very important to study the
process of metastasis in a syngeneic model, no experiments
in immunodeficient mice were performed. However,
injection of MTLn3 cells in the fat pad of nude mice
lacking T- but not NK-cells resulted in only low numbers
of lung metastases [5]. Thus also in these nude mice, NK-
cell mediated killing seems to be responsible for the lack of
metastases. The importance of Natural Killer cells in the
prevention of tumor progression was extensively shown by
Ben-Eliyahu and co-workers [6–8]. Using the MADB106
tumor model in Fischer 344 rats they provide evidence for
the crucial role for NK-cells in resistance to metastasis and
clearly show that external factors influencing susceptibility
to malignancies, such as alcohol intoxication, diverse
pharmacological agents and stress cause a marked decrease
in NK-cell activity [7,8]. Concordant with their findings, in
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Fig. 4 Depleting NK cell from the circulation enables MTLn3 cells
to form experimental metastases. Rats were pre-treated with
mAb3.2.3 to deplete NK cells before 100,000 MTLn3 cells were
injected into the tail vein. After 4 weeks, lungs were isolated, injected
with ink or lung sections were stained with H&E (A) and the number
of surface metastases were counted (B). The incidence (number of
animals with visible lung surface metastsases/total number of animals
in the group), median and significance were determined (C).
Statistical analysis was performed by using the Mann-Whitney Rank
Sum test
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our experiments, NK-cell mediated killing of circulating
tumor cells is responsible for the lack of experimental
metastases. Although the eradication of circulating tumor
cells could be mediated by NK-or T-cells, our data clearly
point toward the NK-cells: First, our in vitro killing assays
show that NK-cells, but not polyclonally activated T-cells
effectively kill MTLn3 cells. Second, the mammary fat pad
experiment [13] shows that intra-organ MTLn3 cells are no
longer a target for the immune system. Third, depletion of
NK-cells by equivalent injection of 3.2.3 mAb by Van den
Brink et al. [17] shows re-appearance of NK- and antibody
dependent cellular cytotoxicity (ADCC) activity after
7 days. As the experiments last 28 days, NK cell activity is
fully restored one week after tumor cell inoculation. Taken
together, these observations show that the MTLn3 cells are
a target for the cellular immune system directly upon
injection into the circulation, probably lasting no more than
24 hours. Thus, no antigen-specific response of the T-cells
towards the MTLn3 cells can be elicited within this limited
time-frame. As the T-cells could respond to the MTLn3
cells by cross-reactivity of a memory population, the cy-
toxocity of polyclonally activated T-cells was tested and
disproven. Although these experiments do not formally
exclude involvement of T-cell mediated processes in the
eradication of MTLn3 cell from the circulation of Fischer
344 rats, our data strongly point towards the Natural Killer
cells as the metastases-preventing factor.
NK cell action is controlled by a balance between
activating and inhibitory signals, the latter mediated by
expression of the appropriate MHC I molecules on the
target cells [2]. Flow cytometric analysis showed that
MTLn3 cells do express MHC-I molecules. Thus either
MTLn3 cells express ligands for the NK cell-activating
receptors tipping the balance towards NK reactivity, or the
MHC molecules are altered and therefore no longer able to
trigger the inhibitory receptors. DNA micro-array data
show that MTLn3 cells express RAE-1 (unpublished
observations), which is a ligand for the activating receptor
NKG2D [19]. The rat homolog of NKG2D, NKR-P2 was
shown to bind a RAE-1 like molecule [20]. In conjunction,
recently it was shown that NKG2D expression protects the
host from tumor initiation [21].
Additionally, a good interaction between target and
effector cell is a prerequisite for efficient NK-mediated
killing, since blocking antibodies against LFA-1 or ICAM-
1 strongly inhibited the cytotoxicity of human NK cell
clones [22]. Prolonged culturing of the MTLn3 cells may
have resulted in the expression of alternative adhesion
molecules. Since these surface molecules are important for
the target-effector interactions, their changed expression
could be responsible for the observed NK cell mediated
killing.
Prevention of the granzyme B/perforin mediated apop-
totic pathway partly reduced the NK cell-induced cyto-
toxicity. The remaining apoptosis is probably not mediated
via TRAIL or FAS-ligand pathways, since exposure of
MTLn3 cells to effector cells expressing either functional
TRAIL or FAS-ligand did not result in apoptosis (data not
shown); in our hands these effector cells efficiently kill
colon tumor cells [23]. The caspase dependency of NK
cell-induced cell death in MTLn3-cells was confirmed by
addition of zVAD-fmk and DEVD-fmk. Interestingly,
prevention of granzyme B-mediated apoptosis in combi-
nation with the pan-caspase inhibitor zVAD-fmk, did not
completely prevent apoptosis. This might indicate that
other proteases, such as cathepsins, may be involved in
apoptosis induction by rat NK cells.
Eradication of the NK cells by pre-treating the rats with
an NK cell depleting antibody resulted in the formation of
more than 130 lung metastases within four weeks after
injection of the cells; these results are comparable to in -
vivo lung metastasis results obtained with earlier passages
of the MTLn3 cells [24]. Therefore, the susceptibility of
the MTLn3 cells to NK cell cytotoxicity can be regarded as
the cause of the lack of lung metastases after tail vein
injection of the MTLn3 cells. This model is now used to
study cell biological pathways of metastasis. Inducible
expression of FRNK, an inhibitor of Focal adhesion kinase
(FAK), prevented metastasis formation, providing evidence
that this method can indeed be used to study the role of
signaling molecules on the process of metastasis [13]. By
using inducible expression of the proteins of interest, the
importance of proteins in the distinct steps of metastasis
can be determined.
In conclusion, we show that NK cells can prevent
metastasis in a syngeneic Fischer 344 model, which could
be overcome by temporal in vivo depletion of the NK cells,
resulting in an improved tumor formation model. The
advantages of a syngeneic model over immunodeficient
models, such as being more representative for the human
situation, are evident.
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